Keytruda and Blopress drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Keytruda (pembrolizumab) and Blopress (candesartan cilexetil). Common drug interactions include anaemia among females and interstitial lung disease among males.
The phase IV clinical study analyzes what interactions people have when they take Keytruda and Blopress. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.
What is Keytruda?
Keytruda has active ingredients of pembrolizumab. It is often used in renal cell carcinoma. eHealthMe is studying from 57,404 Keytruda users. Check the latest studies of Keytruda.
What is Blopress?
Blopress has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 7,479 Blopress users. Check the latest studies of Blopress.
19 people who take Keytruda and Blopress together, and have interactions are studied.

What are the common drug interactions of Keytruda and Blopress, by gender? *:
female:
- Anaemia (lack of blood)
- C-reactive protein increased
- Eosinophilia (eosinophil count in the peripheral blood exceeds)
- Erythema (redness of the skin)
- Neutropenia (an abnormally low number of neutrophils)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Thrombocytopenia (decrease of platelets in blood)
- Blood thyroid stimulating hormone decreased
- Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
- Pyrexia (fever)
male:
- Interstitial lung disease
- Malignant neoplasm progression (cancer tumour came back)
- Erythema (redness of the skin)
- Erythema multiforme (a type of hypersensitivity reaction)
- Malaise (a feeling of general discomfort or uneasiness)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Rash pruritic (redness with itching)
- Skin erosion (a discontinuity of the skin)
- Subcutaneous abscess
- Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
What are the common drug interactions of Keytruda and Blopress, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Anaemia (lack of blood)
- C-reactive protein increased
- Eosinophilia (eosinophil count in the peripheral blood exceeds)
- Erythema (redness of the skin)
- Neutropenia (an abnormally low number of neutrophils)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Thrombocytopenia (decrease of platelets in blood)
60+:
- Interstitial lung disease
- Pyrexia (fever)
- Blood thyroid stimulating hormone decreased
- Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
- Erythema (redness of the skin)
- Erythema multiforme (a type of hypersensitivity reaction)
- Malaise (a feeling of general discomfort or uneasiness)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Rash pruritic (redness with itching)
- Skin erosion (a discontinuity of the skin)
What are the existing conditions these people have? *
- Lung Adenocarcinoma (a form of non-small cell lung cancer): 10 people, 52.63%
- Lumbar Spinal Stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone): 4 people, 21.05%
- Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 21.05%
- Type 2 Diabetes: 2 people, 10.53%
- Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 2 people, 10.53%
- Pain: 2 people, 10.53%
- Lung Cancer - Non-Small Cell (lung cancer): 2 people, 10.53%
- Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 10.53%
- Hyperkalemia (damage to or disease of the kidney): 2 people, 10.53%
- Fever: 2 people, 10.53%
* Approximation only. Some reports may have incomplete information.
Do you take Keytruda and Blopress?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Keytruda and Blopress:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Keytruda:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Blopress:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Keytruda and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Blopress and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on pembrolizumab and candesartan cilexetil (the active ingredients of Keytruda and Blopress, respectively), and Keytruda and Blopress (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Chlor-Trimeton cause Stress And Anxiety? - 5 seconds ago
- Simvastatin vs. Pravastatin Sodium, side effect and effectiveness comparison - 5 seconds ago
- Drug interactions of Hytrin and Atenolol - 23 seconds ago
- Drug interactions of Wellbutrin and Amevive - 26 seconds ago
- Drug interactions of Albuterol and Stiolto Respimat - 27 seconds ago
- Could Lansoprazole cause Viral Upper Respiratory Tract Infection? - 33 seconds ago
- Could Tekturna cause Photophobia? - 34 seconds ago
- Drug interactions of Potassium Chloride and Montelukast Sodium - 36 seconds ago
- Could Lantus cause Ammonia Abnormal? - 40 seconds ago
- Drug interactions of Humulin R and Folate - 54 seconds ago